Addition/Correction pubs.acs.org/OPRD
Correction to Scalable Ruthenium-Catalyzed Asymmetric Synthesis of a Key Intermediate for the β2-Adrenergic Receptor Agonist Masato Komiyama,* Takahiro Itoh, and Takumi Takeyasu Org. Process Res. Dev. 2015, 19, 315−319. DOI: 10.1021/op500338d n page 318, in the procedure for benzyl N-[(2R)-2-[8(benzyloxy)-2-oxo-1,2-dihydroquinolin-5-yl]-2hydroxyethyl]carbamate (2c), the mole of (S,S)-Ms-DENEB (0.0457 kg, 0.0158 mol) was incorrect although the gram is correct. The correct value is 0.0457 kg and 0.0796 mol.
O
Published: January 13, 2016 © 2016 American Chemical Society
325
DOI: 10.1021/acs.oprd.5b00400 Org. Process Res. Dev. 2016, 20, 325−325